New injection shows promise for dangerous fat levels

NCT ID NCT06555640

Completed Disease control Sponsor: Zhejiang Doer Biologics Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new drug called DR10624 in 79 adults with severely high triglycerides, a type of blood fat that raises the risk of heart problems. Participants received injections under the skin for 12 weeks. The main goal was to see if the drug safely lowers triglyceride levels compared to a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertriglyceridemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEVERE HYPERTRIGLYCERIDEMIA

Contacts and locations

Locations

Baoding No.1 Central Hospital

Baoding, China
Chifeng Municipal Hospital

Chifeng, China
Daqing People's Hospital

Daqing, China
Huzhou Central Hospital

Huzhou, China
Inner Mongolia People's Hospital.

Hohhot, China
Lishui Municipal Central Hospital

Lishui, China
Luoyang Third Peoples Hospital

Luoyang, China
Meihekou Central Hospital

Meihekou, China
Nanyang Central Hospital

Nanyang, China
Panjin Liaoyou Baoshihua Hospital

Panjin, China
Peking University First Hospital

Beijing, China
Pingxiang People's Hospital

Pingxiang, China
Second Xiangya Hospital of Central South University

Changsha, China
Shaanxi Provincial People's Hospital

Xi'an, China
The Affiliated Hospital of Hangzhou Normal University

Hangzhou, China
The Affiliated Hospital of Nantong University

Nantong, China
The Affiliated Hospital of Xuzhou Medical University

Xuzhou, China
The First Affiliated Hospital of Baotou Medical College

Baotou, China
The First Affiliated Hospital of Bengbu Medical University

Bengbu, China
The First Affiliated Hospital of Henan University of Science and Technology

Luoyang, China
The First Affiliated Hospital of South China University

Hengyang, China
The First Hospital of Jilin University

Changchun, China
The Fourth Hospital of Harbin Medical University

Harbin, China
The People's Hospital of Liaoning Province

Shenyang, China
The Second Affiliated Hospital of Nanjing Medical University

Nanjing, China
The Second Affiliated Hospital to Nanchang University

Nanchang, China
The Second Hospital of Jilin University

Changchun, China
The Third Affiliated Hospital of Xinjiang Medical University

Xinxiang, China
The Third Hospital of Nanchang

Nanchang, China
Yancheng First People's Hospital

Yancheng, China
Yixing People's Hospital

Yixing, China
Yiyang Central Hospital

Yiyang, China
Yueyang Central Hospital

Yueyang, China
Yuncheng Central Hospital

Yuncheng, China
Zibo Municipal Hospital

Zibo, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.